AC Immune SA Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BVF INC/IL | 02/14/2025 | 19.52 M | $52.71 M | 0.00% | 17.74% |
BLACKROCK, INC. | 02/07/2025 | 2.21 M | $5.97 M | -17.27% | 2.01% |
REDMILE GROUP, LLC | 02/14/2025 | 1.03 M | $2.79 M | -38.95% | 0.94% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 995,636 | $2.69 M | -10.14% | 0.90% |
PLATINUM INVESTMENT MANAGEMENT LTD | 02/11/2025 | 952,069 | $2.57 M | 0.00% | 0.87% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 740,198 | $2.00 M | 14.58% | 0.67% |
NORTHERN TRUST CORP | 02/14/2025 | 403,031 | $1.09 M | 100.00% | 0.37% |
DEUTSCHE BANK AG\ | 02/14/2025 | 253,375 | $684,113 | 0.00% | 0.23% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 198,381 | $528,000 | 331.15% | 0.18% |
MORGAN STANLEY | 02/14/2025 | 166,555 | $449,699 | 156.47% | 0.15% |
HANDELSBANKEN FONDER AB | 02/03/2025 | 150,000 | $405,000 | 0.00% | 0.14% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 131,410 | $354,677 | 130.33% | 0.12% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 119,040 | $321,408 | -28.35% | 0.11% |
MARSHALL WACE, LLP | 02/13/2025 | 66,318 | $179,059 | -33.26% | 0.06% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 64,090 | $173,043 | 9.94% | 0.06% |
UBS GROUP AG | 02/14/2025 | 49,678 | $134,131 | 239.61% | 0.05% |
SQUAREPOINT OPS LLC | 02/14/2025 | 43,784 | $118,217 | 100.00% | 0.04% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 40,818 | $110,209 | -28.79% | 0.04% |
CANTOR FITZGERALD, L. P. | 02/14/2025 | 25,000 | $67,500 | 100.00% | 0.02% |
JANE STREET GROUP, LLC | 02/14/2025 | 24,283 | $65,564 | 100.00% | 0.02% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 23,700 | $63,990 | -80.79% | 0.02% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 20,970 | $56,619 | 10.25% | 0.02% |
RPO LLC | 02/12/2025 | 18,728 | $50,565 | 100.00% | 0.02% |
STATE OF WYOMING | 02/14/2025 | 18,219 | $49,191 | 9.75% | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 14,046 | $37,924 | 100.00% | 0.01% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 13,410 | $36,207 | 100.00% | 0.01% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 11,667 | $31,501 | -18.25% | 0.01% |
QUINN OPPORTUNITY PARTNERS LLC | 02/13/2025 | 10,100 | $27,270 | 100.00% | 0.01% |
COMPAGNIE LOMBARD ODIER SCMA | 01/30/2025 | 10,000 | $27,000 | 0.00% | 0.01% |
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC | 01/14/2025 | 10,000 | $27,000 | 0.00% | 0.01% |
JPMORGAN CHASE & CO | 02/12/2025 | 8,424 | $22,745 | -21.24% | 0.01% |
CITADEL ADVISORS LLC | 02/14/2025 | 7,863 | $21,230 | -63.94% | 0.01% |
CITADEL ADVISORS LLC | 02/14/2025 | 7,600 | $20,520 | -71.64% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 6,913 | $18,665 | 139.62% | 0.01% |
BARCLAYS PLC | 02/13/2025 | 5,872 | $16,000 | 1,098.37% | 0.01% |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/27/2025 | 3,296 | $8,998 | -7.86% | 0.00% |
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 02/07/2025 | 3,123 | $8,432 | -14.74% | 0.00% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 2,888 | $7,797 | -27.42% | 0.00% |
CITIGROUP INC | 02/12/2025 | 2,727 | $7,363 | 55.30% | 0.00% |
02/19/2025 | 2,077 | $5,608 | 100.00% | 0.00% | |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 2,003 | $5,408 | -11.57% | 0.00% |
ACTIVEST WEALTH MANAGEMENT | 01/28/2025 | 1,000 | $2,700 | 0.00% | 0.00% |
ROYAL BANK OF CANADA | 02/14/2025 | 985 | $3,000 | 29.61% | 0.00% |
LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 757 | $2,000 | 100.00% | 0.00% |
02/06/2025 | 544 | $1,469 | 100.00% | 0.00% | |
STRENGTHENING FAMILIES & COMMUNITIES, LLC | 01/29/2025 | 200 | $1,000 | 0.00% | 0.00% |
SJS INVESTMENT CONSULTING INC. | 01/21/2025 | 200 | $540 | 0.00% | 0.00% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
INVESCO LTD. | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
AC Immune SA institutional Ownership - FAQ's
During the previous two years, 59 institutional investors and hedge funds held shares of AC Immune SA. The most heavily invested institutionals were:
BVF INC/IL: 19.52 M
BlackRock, Inc.: 2.21 M
Redmile Group, LLC: 1.03 M
WELLS FARGO & COMPANY/MN: 995,636
PLATINUM INVESTMENT MANAGEMENT LTD: 952,069
RENAISSANCE TECHNOLOGIES LLC: 740,198
24.87% of AC Immune SA stock is owned by institutional investors.
Institutional investors have bought a total of 30.14 M shares in the last 24 months. This purchase volume represents approximately $44.61 M in transactions.